Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
11/03/2004 | EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
11/03/2004 | EP1339716B1 lactam-substituted pyrazolopyridine derivatives |
11/03/2004 | EP1169338B1 Low-molecular inhibitors of complement proteases |
11/03/2004 | EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues |
11/03/2004 | EP0888118B1 Enhancement of microbial colonisation of the gastrointestinal tract |
11/03/2004 | EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
11/03/2004 | EP0729325B1 Osteogenic product and use |
11/03/2004 | CN1543464A Novel imidazopyridine compounds with therapeutic effect |
11/03/2004 | CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
11/03/2004 | CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar) |
11/03/2004 | CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
11/03/2004 | CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine |
11/03/2004 | CN1543345A Methods for selective immunomodulation using pimecrolimus |
11/03/2004 | CN1543343A Preparation and diabetic use of gibberellins |
11/03/2004 | CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot |
11/03/2004 | CN1542010A Azolo triazines and pyrimidines |
11/03/2004 | CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels |
11/03/2004 | CN1541697A Chinese traditional medicine soft capsule for treating chronic cholecystitis and gallstone, and its preparation |
11/03/2004 | CN1541696A Oyster capsule for gastric disease and its preparation |
11/03/2004 | CN1541691A Acute icterohepatitis treating Chinese traditional medicine and its preparation |
11/03/2004 | CN1541688A Traditional Chinese medicine preparation for treating nonspecific colonitis and its preparing process |
11/03/2004 | CN1541680A Chinese traditional medicinal composition Weitashen for replenishing qi, invigorating spleen, calming heart and tranquilizing mind |
11/03/2004 | CN1541674A Traditional Chinese drugs fomula for removing alliaceous odor of mouth cavity rapidly |
11/03/2004 | CN1541673A Kidney nourishing medicated wine |
11/03/2004 | CN1541669A Prepared traditional Chinese drug Liangfu drop pills for treating epigastric pain |
11/03/2004 | CN1541665A Sustained release medicine for treating hepatitis and its preparing process |
11/03/2004 | CN1541657A Medicinal periplaneta americana extracturm extracting process |
11/03/2004 | CN1541651A Unit dosage glycyrrhizicacid diammonium freeze-dry powder injection formulation and its preparation method |
11/03/2004 | CN1173992C Hybrid peptide with vascularization inhibiting activity |
11/03/2004 | CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
11/03/2004 | CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them |
11/03/2004 | CN1173743C Compositions for treatment of disorders of the oesophagus |
11/03/2004 | CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies |
11/03/2004 | CN1173731C Use of Traditonal Chinese medicine composition for curing chronic hepatitis B fibrosis in preparation of medicine for pulmonary fibrosis of SARS |
11/03/2004 | CN1173715C Medicine pill for preventing and treating pathological senility |
11/03/2004 | CN1173711C Donkey-hide gelatin capsule |
11/03/2004 | CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same |
11/03/2004 | CN1173689C Decayed tooth preventing Magnolia Officinalis toothpaste |
11/02/2004 | US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
11/02/2004 | US6812236 Compounds useful in therapy |
11/02/2004 | US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression |
11/02/2004 | US6812219 Methods and compositions for treating flaviviruses and pestiviruses |
11/02/2004 | US6812210 Urocortin-III and uses thereof |
11/02/2004 | US6811781 Composition and method for diagnosing auto-immune hepatitis |
11/02/2004 | US6811769 Oral composition, method of making the oral composition and oral hygiene method in japanese and chinese herbal remedy |
11/02/2004 | CA2338704C Oral liquid mucoadhesive compositions |
11/02/2004 | CA2329486C Reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
11/02/2004 | CA2296970C Neuropeptide y antagonists |
11/02/2004 | CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors |
11/02/2004 | CA2103454C Macrocyclic immunomodulators |
10/28/2004 | WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling |
10/28/2004 | WO2004092169A1 Spiropiperidine compound and medicinal use thereof |
10/28/2004 | WO2004092163A1 Phenylazole compound, production process, and antioxidant drug |
10/28/2004 | WO2004092153A1 Diamine derivative, production process, and antioxidizing drug |
10/28/2004 | WO2004092136A1 Nitrogenous heterocyclic compound and use thereof |
10/28/2004 | WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile |
10/28/2004 | WO2004092118A2 2-propylidene-19-nor-vitamin d compounds |
10/28/2004 | WO2004091665A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
10/28/2004 | WO2004091661A1 Remedy for diabetes |
10/28/2004 | WO2004091643A1 Agent for increasing granulocyte macrophage colony stimulating factor |
10/28/2004 | WO2004091628A1 Receptor antagonist |
10/28/2004 | WO2004091622A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
10/28/2004 | WO2004091611A1 Carbonic anhydrase inhibitors to eradicate helicobacter pylori |
10/28/2004 | WO2004091599A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
10/28/2004 | WO2004091598A1 Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol |
10/28/2004 | WO2004091597A2 Method of treating irritable bowel syndrome (ibs) |
10/28/2004 | WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
10/28/2004 | WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
10/28/2004 | WO2004067093A3 Nk1 receptor antagonists for the treatment of functional dyspepsia |
10/28/2004 | WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
10/28/2004 | WO2004047925A3 Therapeutic oxidation catalysts |
10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
10/28/2004 | WO2003077840A3 Method of modulating inflammatory response |
10/28/2004 | WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
10/28/2004 | WO2001081540A3 Growth factor which acts through erb b-4 rtk |
10/28/2004 | US20040215171 Ingestible device for the release of substances at distinct locations in alimentary canal |
10/28/2004 | US20040215021 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
10/28/2004 | US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders |
10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
10/28/2004 | US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders |
10/28/2004 | US20040214875 Imidazolinylmethyl aralkylsulfonamides |
10/28/2004 | US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
10/28/2004 | US20040214864 Novel compounds |
10/28/2004 | US20040214852 Polysubstituted imidazopyridines |
10/28/2004 | US20040214844 N4-acylcytosine nucleosides for treatment of viral infections |
10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
10/28/2004 | US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens |
10/28/2004 | US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
10/28/2004 | US20040214815 Therapeutic compounds |
10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
10/28/2004 | US20040214794 perorally or rectally administering an effective amount of a lipopolysaccharide isolated from Escherichia coli |
10/28/2004 | US20040214782 caused by infection from Eimeria bovis, Eimeria zuernii or E. aubernensis; administering macrolide antibiotics, azalide class, such as tilmicosin |
10/28/2004 | US20040214780 Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
10/28/2004 | US20040214746 Pharmaceutical composition of a tachykinin receptor antagonist |
10/28/2004 | US20040214275 Von willebrand factor (vmf)-cleaving enzyme |
10/28/2004 | US20040214234 Method |